Recall Enforment Report D-1228-2014

Recall Details

Multi event Drug Recall Enforcement Report Class III voluntary initiated by Novartis Pharmaceuticals Corp., originally initiated on 03-03-2014 for the product Ritalin HCl (methylphenidate HCl) USP, 20 mg, 100 tablets per Bottle, Rx only, Mfd. by: Novartis Pharmaceuticals Corp. Suffern, NY 10901 Dist. by: Novartis Pharmaceuticals Corp. East Hanover, New Jersey 07936, NDC 0078-0441-05 The product was recalled due to labeling: incorrect or missing package insert; the back of the medication guide attached to the package insert for ritalin tablets was printed with information related to ritalin sr (sustained release) tablets. both products, ritalin tablets and ritalin sr tablets utilize a combined package insert. the individual medication guides are attached to the package insert via a perforation. although t. The product was distributed nationwide and the recall is currently terminated.

Recall Enforcement Reports

Recall Number Recall Initiation Date Report Date Recall Classification Quantity Product Description Recall Reason Status
D-1228-201403-03-201404-16-2014Class III10,781 bottlesRitalin HCl (methylphenidate HCl) USP, 20 mg, 100 tablets per Bottle, Rx only, Mfd. by: Novartis Pharmaceuticals Corp. Suffern, NY 10901 Dist. by: Novartis Pharmaceuticals Corp. East Hanover, New Jersey 07936, NDC 0078-0441-05Labeling: Incorrect or Missing Package Insert; The back of the Medication Guide attached to the Package Insert for Ritalin Tablets was printed with information related to Ritalin SR (Sustained Release) Tablets. Both products, Ritalin Tablets and Ritalin SR Tablets utilize a combined Package Insert. The individual Medication Guides are attached to the Package Insert via a perforation. Although tTerminated
D-1227-201403-03-201404-16-2014Class III10,930 BottlesRitalin HCl (methylphenidate HCl) USP, 10 mg, 100 tablets per Bottle, Rx only, Mfd. by: Novartis Pharmaceuticals Corp. Suffern, NY 10901, Dist. by: Novartis Pharmaceuticals Corp. East Hanover, New Jersey 07936, NDC 0078-0440-05Labeling: Incorrect or Missing Package Insert; The back of the Medication Guide attached to the Package Insert for Ritalin Tablets was printed with information related to Ritalin SR (Sustained Release) Tablets. Both products, Ritalin Tablets and Ritalin SR Tablets utilize a combined Package Insert. The individual Medication Guides are attached to the Package Insert via a perforation. Although tTerminated

Recalled Products

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
0078-0439Ritalin Methylphenidate HydrochlorideTabletOralNovartis Pharmaceuticals CorporationHuman Prescription Drug
0078-0440Ritalin Methylphenidate HydrochlorideTabletOralNovartis Pharmaceuticals CorporationHuman Prescription Drug
0078-0441Ritalin Methylphenidate HydrochlorideTabletOralNovartis Pharmaceuticals CorporationHuman Prescription Drug